Standort in Deutschland, wo man günstige und qualitativ hochwertige Kamagra Ohne Rezept Lieferung in jedem Teil der Welt zu kaufen.
Wenn das Problem der Verringerung der Potenz berührt mich persönlich war ich schockiert, dass das passiert gerade mit mir cialis Übrigens jeder leisten und gibt eine sofortige Wirkung ohne Hausarbeiten Anwendungen.
He althcare Technology Co-operative
Daily Mail report on PTNS
In late August there was an article in the Daily Mail’s ‘Good Health’ section
reporting on the multicentre trial of PTNS (percutaneous tibial nerve
stimulation) being led by NIHR Enteric HTC in conjunction with Bowel and
The article focused on a case study involving a patient who had developed
chronic faecal incontinence in later life as a result of the effects of childbirth on
the nerves and muscles in the lower abdomen. In her case, PTNS had proved
to be very successful and had restored her quality of life. The case highlights
a key element of NIHR Enteric HTC’s remit, which is to engage in research
and clinical trials which will greatly benefit patients.
Professor Charles Knowles, Co-Clinical Director of the HTC, contributed to the
article, explaining the problems associated with faecal incontinence, believed
to affect 10% of adults, rising to 50% in advanced age. In addition to childbirth,
other causes included pelvic organ prolapse, previous anal or pelvic surgery or
radiotherapy. Patients are often prescribed anti-diarrhoeal medication such as
loperamide in the first instance, possibly alongside dietary and exercise
One existing option is sacral nerve stimulation (SNS), involving surgery to
insert electrodes in the lower back which connect to an electrical stimulator
of the pilot HTC, enteric. implanted in the buttock to send electrical impulses to the nerves controlling
the bowel and sphincter. This has proved effective in about 75% of cases over
the last 15 years, but is expensive (c.£10,000 per patient) and invasive.
It is hoped that PTNS will prove to be a cheaper and simpler alternative in the
longer term, following the results of the ongoing trial.
NIHR Enteric HTC is pleased to report that recruitment for
the trial was successfully completed, with 227 patients.
The results will now be evaluated and a final report will be produced within six months.
Advance Notice – Event 2014
NIHR Enteric HTC is planning to hold a joint event in collaboration with CLRN in London in 2014.
Further information will follow in due course.
NIH R Enteric
International Innovation and NCBRSI
HTC Core Team
In a recent issue of the magazine ‘International Innovation’, there was an article
highlighting the work of the National Centre for Bowel Research and Surgical
Innovation. Professor Charles Knowles introduced the Centre, which is based
around a human tissue laboratory and is the base for the charity Bowel & Cancer
Research. Professor Knowles explained how linking research across the UK will
lead to significant progress in the understanding and treatment of diseases of the
gastrointestinal tract. Further information is available on the following link:
Recruitment for the study on the GEKO™ device has now been completed.
This is being led by Kathryn Gill, Consultant Surgeon, and other clinic
partners at Sandwell and West Birmingham NHS Trust.
It is expected results will be available early 2014.
EPSRC-NIHR Healthcare Technology Co-operatives Partnership Awards
The Engineering and Physical Sciences Research Council (EPSRC), in conjunction with the National
Institute for Health Research (NIHR), has issued a call for network proposals aimed at facilitating
collaborations between academic institutions and the eight NIHR-funded Healthcare Technology Co-
operatives. Each network proposal must be led by an eligible academic institution. Funding is available
up to £150,000 for a maximum of three years. Each proposal must be supported by at least one HTC,
but no more than three. The closing date for applications is 7 January 2014.
Further information is available on the EPSRC website on the following link:
NIHR Enteric HTC is pleased to welcome James Haddow
as the new Clinical
Network Co-ordinator to assist in developing the HTC’s expanding network of
contacts in the UK. In September, James received the Dark Horse Award from
Queen Mary Innovation as part of the Barts Health Innovation in Healthcare 2013
Awards, for his work in developing the Implant-ID microchip technology to
improve identification of medical implants.
The HTC is also pleased to confirm that a new Research Fellow, Kathryn Lynes,
has been appointed under the Royal College of Surgeons David Johnston Fellowship
to work on the research programme focusing on sphincter preservation in rectal
Product insert for testing any of the following drugs: Amphetamine, Barbiturates, Benzodiazepines, Cocaine, Erimin, Ketamine, Marijuana, Methamphetamine, & Morphine. INTENDED USE WARNINGS AND PRECAUTIONS FastScreen™ Single Drug Test is a rapid, competitive binding 1. For professional in vitro diagnostic use only. immunoassay for qualitative determination of differ
Isabella’s® All Natural Raisin Bran Fat Free Muffins (#12403016) INGREDIENTS: WATER, UNBLEACHED, UNBROMATED, ENRICHED FLOUR (wheat flour, malted barley flour, niacin, reduced iron, thiamin mononitrate, riboflavin, folic acid), NONFAT MILK, MOLAS-SES, RAISINS, HONEY, WHEAT BRAN, EGG WHITES, EVAPORATED CANE JUICE, FRUIT FLAKE POWDER (pear, apple, plum), Contains less